“…Over the years, advances in lipidomics (Züllig & Köfeler, 2020) have allowed global lipid profiling in AD research showing significant alterations of AD brain lipid metabolism (Chan et al, 2012;Han et al, 2001Han et al, , 2002Pernber et al, 2012;Snowden et al, 2017). In the last decade, the combination of immunohistochemistry and microdissection technology to visualize and dissect Aβ-plaques followed by liquid chromatography (LC)-electrospray ionization (ESI) MS (Gaudin et al, 2012;Panchal et al, 2010Panchal et al, , 2014 and MS-based imaging techniques (Carlred et al, 2014(Carlred et al, , 2016Kaya et al, 2018;Michno et al, 2018Sole-Domenech et al, 2013;Strnad et al, 2019;Tian et al, 2019) resulted in powerful tool boxes capable of successfully detecting and correlating multiple targets of AD pathogenesis with about cellular spatial resolution (Figure 1). Together, these techniques help to elucidate the multifaceted chemical build-up of Aβ-plaques and enable a comprehensive discussion of possible pathophysiological pathways involved in plaque-associated lipid alterations and of Aβ-lipid interactions (Table 1).…”